324 related articles for article (PubMed ID: 16225471)
1. Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
3. Steatosis and hepatocellular carcinoma risk.
Smedile A; Bugianesi E
Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
[TBL] [Abstract][Full Text] [Related]
4. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
7. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
[TBL] [Abstract][Full Text] [Related]
8. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
9. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
10. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
11. Is liver disease a threat to patients with metabolic disorders?
Marchesini G; Forlani G; Bugianesi E
Ann Med; 2005; 37(5):333-46. PubMed ID: 16179269
[TBL] [Abstract][Full Text] [Related]
12. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
[TBL] [Abstract][Full Text] [Related]
13. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
15. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
Trombetta M; Spiazzi G; Zoppini G; Muggeo M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
[TBL] [Abstract][Full Text] [Related]
16. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
17. Steatosis: co-factor in other liver diseases.
Powell EE; Jonsson JR; Clouston AD
Hepatology; 2005 Jul; 42(1):5-13. PubMed ID: 15962320
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
Baffy G; Brunt EM; Caldwell SH
J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
[TBL] [Abstract][Full Text] [Related]
19. Obesity, fatty liver and liver cancer.
Qian Y; Fan JG
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
